APA (7th ed.) Citation

Wang, T., Zhu, X., Chen, Y., Shen, S., Tang, Y., Zhang, J., . . . Zhang, M. (2023). Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin's Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study. Drugs in R&D, 23(2), 129. https://doi.org/10.1007/s40268-023-00420-y

Chicago Style (17th ed.) Citation

Wang, Tianyou, et al. "Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin's Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study." Drugs in R&D 23, no. 2 (2023): 129. https://doi.org/10.1007/s40268-023-00420-y.

MLA (9th ed.) Citation

Wang, Tianyou, et al. "Safety and Effectiveness of Rasburicase in the Control of Hyperuricemia in Pediatric Patients with Non-Hodgkin's Lymphoma and Acute Leukemia: An Open-Label, Single-Arm, Multi-center, Interventional Study." Drugs in R&D, vol. 23, no. 2, 2023, p. 129, https://doi.org/10.1007/s40268-023-00420-y.